Breast and Ovarian Cancer Prevention Program

If you believe you have a high risk of developing breast or ovarian cancer, you may want to make an appointment at the Breast and Ovarian Cancer Prevention Program, which is part of the Women's Center on the third floor of the SCCA clinic.

 

This specialized program offers a personalized approach to cancer risk assessment, prevention, and screening.

 

You may be at high risk to develop breast or ovarian cancer (or both) if:

• You have a strong family history, OR
• You have had an abnormal result on a BRCA1 or BRCA2 genetic test, OR
• A biopsy has shown that you have atypical hyperplasia or carcinoma in situ (DCIS or LCIS).

If you would like to schedule an appointment or to learn more, please call (206) 288-6990.

At your appointment, you will meet with a team of breast and ovarian cancer experts. These include a medical oncologist, a genetic counselor, a breast surgeon, a nutritionist, and a gynecologic oncologist. You will receive information about risk factors and strategies to reduce your risk, including a comprehensive, personal program for cancer prevention and early detection.

In addition, women who are at high risk for breast or ovarian cancer, and who have been seen at the Breast and Ovarian Cancer Prevention Program, may be referred to the Women’s Wellness Clinic for routine medical exams and close monitoring. These women do not have cancer, but they come to the Women’s Wellness Clinic for help with cancer prevention.

In the News
Physicians at SCCA and UWMC offer new preventative solutions to women with a strong family history of cancer. To watch the King-5 video, click here.

DEFINITION:

Strong family history If you have two or more relatives on the same side of your family with breast or ovarian cancer, especially if the breast cancer was diagnosed before the age of 50, or if you have a male relative with breast cancer, or a relative who has had two primary breast cancers or breast and ovarian cancer both, then you are at high risk for developing either breast or ovarian cancer.

 

October 2007